Breast cancer screening halves the risk of breast cancer death: A case-referent study

Breast

Volumn 23, Issue 4, 2014, Pages 439-444

  Paap, Ellen ^a,b   Verbeek, André L M ^a   Botterweck, Anita A M ^c   van Doorne Nagtegaal, Heidi J ^c   Imhof Tas, Mechli ^a,d   de Koning, Harry J ^e   Otto, Suzie J ^e   de Munck, Linda ^c   van der Steen, Annemieke ^f   Holland, Roland ^b   den Heeten, Gerard J ^b,g   Broeders, Mireille J M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b National Expert and Training Centre for Breast Cancer Screening   (Netherlands)

^c Department of Registration and Research   (Netherlands)

^d Screening Program Early detection of breast cancer   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f Screening Program Early Detection of Breast Cancer in the South West Part of the Netherlands   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Breast cancer; Case referent study; Effectiveness; Mammography; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PATIENT PARTICIPATION; PRIORITY JOURNAL; RURAL AREA; BREAST TUMOR; MIDDLE AGED; MORTALITY; RADIOGRAPHY; STATISTICAL MODEL;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED;

EID: 84902548562     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2014.03.002     Document Type: Article

References (50)

1. Nelson H.D., Tyne K., Naik A., Bougatsos C., Chan B.K., Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 151(10):727-742.
2. Broeders M., Moss S., Nystrom L., Njor S., Jonsson H., Paap E., et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. JMed Screen 2012, 19(Suppl.1):14-25.
3. Jorgensen K.J., Keen J.D., Gotzsche P.C. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality?. Radiology 2011 Sep, 260(3):621-627.
4. McPherson K. Screening for breast cancer-balancing the debate. BMJ 2010, 340:c3106.
5. Verbeek A.L.M., Broeders M.J.M. Evaluation of cancer service screening: case referent studies recommended. Stat Methods Med Res 2010, 19:487-505.
6. Broeders M.J.M., Verbeek A.L.M. Mammographic screening only matters in the detectable preclinical period of breast cancer [letter]. JMed Screen 2005, 12(2):107.
7. Concato J., Shah N., Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. NEngl J Med 2000, 342(25):1887-1892.
8. Demissie K., Mills O.F., Rhoads G.G. Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography. JClin Epidemiol 1998, 51(2):81-91.
9. Corder A.P. Screening for breast cancer. "Mega-trial" needed. BMJ 2010, 341:c4453.
10. Harris R., Yeatts J., Kinsinger L. Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence. Prev Med 2011 Sep, 53(3):108-114.
11. Jorgensen K.J. Flawed methods explain the effect of mammography screening in Nijmegen. Br J Cancer 2011 Aug 9, 105(4):592-593. [author reply 4-5].
12. Autier P., Boniol M. Mammography screening and breast cancer mortality-letter. Cancer Epidemiol Biomarkers Prev 2012 May, 21(5):869. [author reply 70-1].
13. Paap E., Verbeek A.L.M., Puliti D., Broeders M.J.M., Paci E. Minor influence of self-selection bias on the effectiveness of breast cancer screening in case-control studies in the Netherlands. JMed Screen 2011, 18:142-146.
14. National Evaluation Team for Breast Cancer Screening NETB interim report 2011. Main results 2008-2009 breast cancer screening programme in the Netherlands 2011, Dept. of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam.
15. Paap E., Verbeek A.L.M., Puliti D., Paci E., Broeders M.J.M. Breast cancer screening case-control study design: impact on breast cancer mortality. Ann Oncol 2011, 22(4):863-869.
16. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976 Feb, 103(2):226-235.
17. Harteloh P., de Bruin K., Kardaun J. The reliability of cause-of-death coding in The Netherlands. Eur J Epidemiol 2010 Aug, 25(8):531-538.
18. Garne J.P., Aspegren K., Balldin G. Breast cancer as cause of death-a study over the validity of the officially registered cause of death in 2631 breast cancer patients dying in Malmo, Sweden 1964-1992. Acta Oncol 1996, 35(6):671-675.
19. Goldoni C.A., Bonora K., Ciatto S., Giovannetti L., Patriarca S., Sapino A., et al. Misclassification of breast cancer as cause of death in a service screening area. Cancer Causes Control 2009, 20(5):533-538.
20. Nyström L., Larsson L.G., Rutqvist L.E., Lindgren A., Lindqvist M., Ryden S. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials; a comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995, 34:145-152.
21. Health Council of the Netherlands Usefulness of population breast cancer screening (in Dutch) 2002, Health Council of the Netherlands, The Hague, publication no. 2002/03.
22. Greenland S., Thomas D.C. On the need for the rare disease assumption in case-control studies. Am J Epidemiol 1982 Sep, 116(3):547-553.
23. Vandenbroucke J.P., Pearce N. Case-control studies: basic concepts. Int J Epidemiol 2012 Oct, 41(5):1480-1489.
24. Vandenbroucke J.P., Pearce N. Incidence rates in dynamic populations. Int J Epidemiol 2012 Oct, 41(5):1472-1479.
25. Weiss N.S., McKnight B., Stevens N.G. Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 1992, 135(7):817-823.
26. Roder D., Houssami N., Farshid G., Gill G., Luke C., Downey P., et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 2008, 108(3):409-416.
27. Zackrisson S., Andersson I., Manjer J., Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004, 108(5):754-760.
28. Duffy S.W., Cuzick J., Tabar L., Vitak B., Chen T.H.H., Yen M.F., et al. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. Appl Stat 2002, 51(Part 2):235-243.
29. Paci E., Duffy S.W., Giorgi D., Zappa M., Crocetti E., Vezzosi V., et al. Quantification of the effect of mammographic screening on fatal breast cancers: the Florence Programme 1990-96. Br J Cancer 2002, 87(1):65-69.
30. Rothman K., Greenland S., Lash T. Modern epidemiology 2008, Wolters Kluwer Health/Lippincott Williams &Wilkins, Philadelphia.
31. Weiss N.S. Application of the case-control method in the evaluation of screening. Epidemiol Rev 1994, 16(1):102-108.
32. Egger M., Davey Smith G., Altman D.G. Systematic reviews in health care: meta-analysis in context 2001, BMJ Books, London. 2nd ed.
33. Nickson C., Mason K.E., English D.R., Kavanagh A.M. Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012 Sep, 21(9):1479-1488.
34. Fielder H.M., Warwick J., Brook D., Gower-Thomas K., Cuzick J., Monypenny I., et al. Acase-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. JMed Screen 2004, 11(4):194-198.
35. Otto S.J., Fracheboud J., Verbeek A.L., Boer R., Reijerink-Verheij J.C., Otten J.D., et al. Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2012 Jan, 21(1):66-73.
36. Paap E., Holland R., den Heeten G.J., van Schoor G., Botterweck A.A.M., Verbeek A.L.M., et al. Aremarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes Control 2010, 21(10):1569-1573.
37. van Schoor G., Moss S.M., Otten J.D., Donders R., Paap E., den Heeten G.J., et al. Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 2011, 104(6):910-914.
38. Holland R., Rijken H., Hendriks J.H.C.L. The Dutch population-based mammography screening: 30-year experience. Breast Care 2007, 2:12-18.
39. Gabe R., Tryggvadottir L., Sigfusson B.F., Olafsdottir G.H., Sigurdsson K., Duffy S.W. Acase-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 2007, 48(9):948-955.
40. Olsen A.H., Njor S.H., Vejborg I., Schwartz W., Dalgaard P., Jensen M.B., et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005, 330(7485):220.
41. Puliti D., Miccinesi G., Collina N., De Lisi V., Federico M., Ferretti S., et al. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 2008, 99(3):423-427.
42. Swedish Organised Service Screening Evaluation Group Reduction in breast cancer mortality from the organised service screening with mammography: 2. Validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev 2006, 15(1):52-56.
43. Otto S.J., Fracheboud J., Verbeek A.L., Boer R., Reijerink-Verheij J., Otten J.D., et al. Mammography screening and breast cancer mortality - response. Cancer Epidemiol Biomarkers Prev 2012, 21:870-871.
44. Elmore J.G., Reisch L.M., Barton M.B., Barlow W.E., Rolnick S., Harris E.L., et al. Efficacy of breast cancer screening in the community according to risk level. JNatl Cancer Inst 2005, 97(14):1035-1043.
45. van Schoor G., Paap E., Broeders M.J.M., Verbeek A.L.M. Residual confounding after adjustment for age: a minor issue in breast cancer screening effectiveness. Eur J Epidemiol 2011, 26:585-588.
46. Nickson C., Mason K.E., English D.R., Kavanagh A.M. Screening and breast cancer mortality - response. Cancer Epidemiol Biomarkers Prev 2012, 21(12):2276-2277.
47. Health Council of the Netherlands Population screening of breast cancer: expectations and developments (in Dutch) 2014, Health Council of the Netherlands, The Hague, Publication no. 2014/01.
48. Hoff S.R., Klepp O., Hofvind S. Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?. JMed Screen 2012, 19(4):177-183.
49. Vanier A., Leux C., Allioux C., Billon-Delacour S., Lombrail P., Molinie F. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France). Cancer Epidemiol 2013, 37(5):683-687.
50. Sasco A.J., Day N.E., Walter S.D. Case-control studies for the evaluation of screening. JChronic Dis 1986, 39(5):399-405.